Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Osteosarcoma × Metastasectomy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 2 Sarcoma 1 Prostatic Neoplasms 1 Osteosarcoma 1 Lymphatic Metastasis 1 Ependymoma 1 Clear-cell metastatic renal cell carcinoma 1 Carcinoma, Renal Cell 1

Interventions

Ifosfamide 13 Doxorubicin 10 Methotrexate 9 Filgrastim 8 Cisplatin 8 Cyclophosphamide 7 Magnetic Resonance Spectroscopy 6 Etoposide 6 X-Rays 5 Specimen Handling 5 Sirolimus 5 Phantoms, Imaging 5 Neoadjuvant Therapy 5 Leucovorin 5 Gemcitabine 5 Nuclear Medicine Department, Hospital 4 Nivolumab 4 Drug Therapy 4 Docetaxel 4 Biopsy 4 regorafenib 3 palbociclib 3 olaparib 3 mifamurtide 3 cixutumumab 3 camrelizumab 3 cabozantinib 3 apatinib 3 Vincristine 3 Topotecan 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06114225 2023-11-02

PROMIS

Ruijin Hospital

Phase 2 Recruiting

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡